Qualigen Therapeutics Inc.
QLGN | NASDAQ
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.19M | -6.08M | -10.6M | -2.04M | -1.69M | -2.65M | -855.82K | -1.79M | -1.48M | -2.03M | -2.47M | -3.2M | -3.51M | -2.97M | -8.53M | -2.91M | -4.13M | -4.32M | -6.06M | -3.04M | -6.97M | -3.67M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.5K | n/a | 122.79K | n/a | 109.99K | 89.55K | 91.82K | 84.24K | 89.22K | 85.61K | 81.82K | 81.63K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | 269 | 9.11K | 27.21K | 33.09K | 58.65K | 69.69K | 142.4K | 653.92K | 252.23K | 1.38M | 1.41M | 1.42M | 1.27M | 1.43M | 1.31M | 1.29M | 1.26M |
Other Working Capital | -329.9K | -976.84K | 973.32K | -364.25K | 418.72K | 973.32K | -1.1M | -485.34K | 222.78K | 1.02M | -295.07K | 88.86K | -533.45K | 298.4K | 245.33K | 424.97K | -1.27M | -224.36K | -247 | 80.64K | -798.69K | 2.39M |
Other Non-Cash Items | 1.26M | 2.34M | 7.54M | 382.98K | 294.71K | 120.52K | -461.83K | 667.78K | -306.4K | 587.67K | -4.21M | 3.98M | 254.18K | -129.16K | 4.28M | -417.7K | -22.45K | -767.3K | 1.33M | -1.67M | -507.73K | -1.98M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 572.47K | n/a | -410.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -519.58K | -760.11K | 935.99K | -486.64K | 292.59K | 935.99K | -960.98K | -700.79K | 275.34K | 602.85K | 356.09K | 141.38K | -40.86K | 469.1K | 521.11K | 59.36K | -1.31M | -145.94K | 301.92K | 277.31K | -596.8K | 2.23M |
Operating Cash Flow | -3.44M | -4.5M | -2.12M | -2.14M | -1.1M | -1.59M | -2.27M | -1.8M | -1.47M | -783.59K | -5.67M | 929.74K | -2.93M | -2.63M | -2.24M | -3.18M | -3.95M | -3.88M | -2.91M | -3.03M | -6.7M | -2.08M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4 | n/a | 246.42K | -48.41K | 3 | -244.37K | 63.49K | -13.86K | -49.63K | -17.01K | -9.67K | -45.69K | -69K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -135.35K | 135.35K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | 1.52M | n/a | -1.21M | -305K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.82M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 9.82M | -8.5M | -15.59M | -291K | -1.21M | -305K | -1.01M | -1.25M | 350K | n/a | 235.4K | 3.98M | -48.41K | -198.01K | -244.38K | 60.61K | 135.35K | n/a | -8.82M | n/a | -156 | -6.74K |
Investing Cash Flow | 9.82M | -8.5M | -14.07M | -291K | -1.21M | -305K | -1.01M | -1.25M | 350K | n/a | 235.4K | 4.23M | -48.41K | -198.01K | -244.37K | -11.26K | 121.5K | -49.63K | -17.01K | -9.67K | -45.69K | -69K |
Debt Repayment | n/a | -132K | -2.33M | -1.03M | 2.61M | 750K | -499.02K | n/a | 1M | 475K | n/a | -440K | n/a | n/a | 2.9M | n/a | n/a | n/a | n/a | n/a | -15.61K | -123.13K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -1.69M | n/a | -1.59K | n/a | n/a | -87.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12M | n/a | 45.98M | n/a | -3.29M | n/a | 4.56M | 87.6K | 150K | n/a | -110K | n/a | n/a | n/a | -505 | n/a | n/a | 3.86K | -671.2K | 129.43K | 49.74K | 244.58K |
Financial Cash Flow | -12M | -132K | -3.25M | 40.88M | 2.61M | 750K | 4.06M | 3.32M | 1.15M | 475K | -110K | -440K | n/a | n/a | 2.9M | 3.31K | 1 | 3.86K | 8.15M | 129.43K | 34.13K | 121.45K |
Net Cash Flow | -5.62M | -13.13M | -19.44M | 38.45M | 301.39K | -1.14M | 786.46K | 269.47K | 25.47K | -308.59K | -1.67M | 732.19K | -3.02M | 1.2M | 416.36K | -3.13M | -3.86M | -3.93M | 5.22M | -2.91M | -6.72M | -2.03M |
Free Cash Flow | -3.44M | -4.5M | -2.12M | -2.14M | -1.1M | -1.59M | -2.27M | -1.8M | -1.47M | -783.59K | -5.67M | 1.18M | -2.98M | -2.63M | -2.48M | -3.12M | -3.96M | -3.93M | -2.93M | -3.04M | -6.75M | -2.15M |
Adj. Free Cash Flow | -3.44M | -4.5M | -2.12M | -2.14M | -1.1M | -1.59M | -2.28M | -1.83M | -1.51M | -842.24K | -5.74M | 1.03M | -3.63M | -2.89M | -3.87M | -4.53M | -5.38M | -5.2M | -4.36M | -4.36M | -8.04M | -3.41M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4 | n/a | 246.42K | -35.44K | 6 | -244.37K | 85.27K | n/a | -49.63K | n/a | n/a | -26.83K | -29.95K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.97K | -3 | n/a | -21.79K | -13.86K | n/a | -17.01K | -9.67K | -18.86K | -39.05K |
Owner Earnings | -3.44M | -4.5M | -2.12M | -2.14M | -1.1M | -1.59M | -2.27M | -1.8M | -1.47M | -783.59K | -5.67M | 1.18M | -2.96M | -2.63M | -2.48M | -3.1M | -3.95M | -3.93M | -2.91M | -3.03M | -6.73M | -2.11M |
Add to Watchlist
Select watchlists to add or remove QLGN